drugset / Trial / NCT00680732
Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component
Phase 4
Completed
1370 enrolled
Institute of Tropical Medicine, Belgium
Centre Muraz · collabDepartments of Parasitology and Public Health, ITM, Antwerp, Belgium · collabLaboratoire National de Santé Publique, Ouagadougou, Burkina Faso · collab
RandomizedFactorialOpen-labelPrevention
Summary
Our objective was to investigate the importance of malaria infection/disease during pregnancy and more particularly during the first trimester; we also looked at the maternal-foetal interactions and their influence on the subsequent child's response to malaria infections during the first year of life. This study was carried out !in the same population recruited for the IUGR study (NCT00642408).
Timeline
- Start
- 2003-06
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chloroquine | Small molecule | 100 mg | — |
| Subject | Sulphadoxyne-pyrimethamine | Unknown | — | — |